Skip to main content

Senators ask CEOs why their drugs cost so much more in the U.S.

   February 09, 2024

The executives from Bristol Myers Squibb, Johnson & Johnson and Merck spent almost three hours in front of the committee going back and forth about pricing practices and how the companies spend their money.

Full story

Get the latest on healthcare leadership in your inbox.